Sanofi (SNYNF) Assets (2009 - 2026)

Sanofi has disclosed Assets across 18 years of filings, most recently posting $149.9 billion for Q1 2026.

• Assets for Q1 2026 came in at $149.9 billion, up 8.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $149.9 billion (up 8.04% YoY), and the FY2025 annual result was $147.6 billion, up 4.02% from the prior year.
• Assets came in at $149.9 billion for Q1 2026 at Sanofi, up from $147.6 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $151.7 billion in Q3 2025 to a low of $129.3 billion in Q4 2022.
• The 5-year median for Assets is $139.7 billion (2024), against an average of $140.3 billion.
• Across the five-year window, Assets fell 6.01% in 2022 and climbed 8.04% in 2026, its largest moves.
• Sanofi's Assets stood at $129.3 billion in 2022, then climbed by 5.24% to $136.1 billion in 2023, then climbed by 4.29% to $141.9 billion in 2024, then grew by 4.02% to $147.6 billion in 2025, then increased by 1.54% to $149.9 billion in 2026.
• The last three Assets figures came in at $149.9 billion (Q1 2026), $147.6 billion (Q4 2025), and $151.7 billion (Q3 2025), per Business Quant data.